Estimating the effective sample size in association studies of quantitative traits.


Journal

G3 (Bethesda, Md.)
ISSN: 2160-1836
Titre abrégé: G3 (Bethesda)
Pays: England
ID NLM: 101566598

Informations de publication

Date de publication:
17 06 2021
Historique:
received: 09 12 2020
accepted: 06 01 2021
pubmed: 19 3 2021
medline: 15 11 2022
entrez: 18 3 2021
Statut: ppublish

Résumé

The effective sample size (ESS) is a metric used to summarize in a single term the amount of correlation in a sample. It is of particular interest when predicting the statistical power of genome-wide association studies (GWAS) based on linear mixed models. Here, we introduce an analytical form of the ESS for mixed-model GWAS of quantitative traits and relate it to empirical estimators recently proposed. Using our framework, we derived approximations of the ESS for analyses of related and unrelated samples and for both marginal genetic and gene-environment interaction tests. We conducted simulations to validate our approximations and to provide a quantitative perspective on the statistical power of various scenarios, including power loss due to family relatedness and power gains due to conditioning on the polygenic signal. Our analyses also demonstrate that the power of gene-environment interaction GWAS in related individuals strongly depends on the family structure and exposure distribution. Finally, we performed a series of mixed-model GWAS on data from the UK Biobank and confirmed the simulation results. We notably found that the expected power drop due to family relatedness in the UK Biobank is negligible.

Identifiants

pubmed: 33734375
pii: 6178001
doi: 10.1093/g3journal/jkab057
pmc: PMC8495748
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA194393
Pays : United States
Organisme : NHGRI NIH HHS
ID : R21 HG007687
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Genetics Society of America.

Auteurs

Andrey Ziyatdinov (A)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Jihye Kim (J)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Dmitry Prokopenko (D)

Genetics and Aging Unit and McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.
Harvard Medical School, Boston, MA 02115, USA.

Florian Privé (F)

National Centre for Register-Based Research, Aarhus University, Aarhus 8210, Denmark.

Fabien Laporte (F)

Department of Computational Biology-USR 3756 CNRS, Institut Pasteur, Paris 75015, France.

Po-Ru Loh (PR)

Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Peter Kraft (P)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Hugues Aschard (H)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Department of Computational Biology-USR 3756 CNRS, Institut Pasteur, Paris 75015, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH